Pharmacological cholinergic stimulation as a therapeutic tool in experimental necrotizing pancreatitis

Pancreas

Volumn 43, Issue 1, 2014, Pages 41-46

  Schneider, Lutz ^a   Jabrailova, Bahar ^a   Soliman, Hussein ^a   Hofer, Stefan ^a   Strobel, Oliver ^a   Hackert, Thilo ^a   Büchler, Markus W ^a   Werner, Jens ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

acute pancreatitis; cholinergic anti inflammatory pathway; nervus vagus

Indexed keywords

CELL ENZYME; GLYCODEOXYCHOLIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; MYELOPEROXIDASE; NEOSTIGMINE; NICOTINE; PANCREAS ENZYME; PHYSOSTIGMINE;

ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY MASS; CHOLINERGIC ACTIVITY; CHOLINERGIC STIMULATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME BLOOD LEVEL; LEUKOCYTE; LOADING DRUG DOSE; MALE; NONHUMAN; PANCREAS NECROSIS; PANCREATITIS; PRIORITY JOURNAL; RAT; SHAM PROCEDURE;

ANIMALS; CHOLINERGIC AGENTS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCODEOXYCHOLIC ACID; HMGB1 PROTEIN; HUMANS; MALE; NEOSTIGMINE; NICOTINE; PANCREAS; PANCREATITIS, ACUTE NECROTIZING; PEROXIDASE; PHYSOSTIGMINE; RATS; RATS, WISTAR;

EID: 84891510669     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182a85c21     Document Type: Article

References (46)

1. Schneider L, Buchler MW, Werner J. Acute pancreatitis with an emphasis on infection. Infect Dis Clin North Am. 2010;24(4):921-941, viii.
2. Steer ML. Etiology and pathophysiology of acute pancreatitis. In Go VLV, Dimagno EP, Gardner JD, Lebenthal E, Reber A, Scheele GA, eds. The Pancreas: Biology, Pathophysiology, and Disease. New York, NY: Raven; 1993:581-592.
3. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg. 1998;175(1):76-83. (Pubitemid 28047037)
4. Gross V, Leser HG, Heinisch A, et al. Inflammatory mediators and cytokinesVnew aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology. 1993;40(6):522-530. (Pubitemid 24006279)
5. Werner J, Z'Graggen K, Fernandez-del Castillo C, et al. Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM-1. Ann Surg. 1999;229(6):834-840; discussion 841-842.
6. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117(2):289-296. (Pubitemid 46203953)
7. Tracey KJ. The inflammatory reflex. Nature. 2002;420(6917):853-859. (Pubitemid 36019638)
8. Pavlov VA, Wang H, Czura CJ, et al. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med. 2003;9(5-8):125-134. (Pubitemid 37310949)
9. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405(6785):458-462. (Pubitemid 30367422)
10. Wang H, Liao H, Ochani M, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med. 2004;10(11):1216-1221. (Pubitemid 39540438)
11. Schneider L, Hartwig W, Flemming T, et al. Protective effects and anti-inflammatory pathways of exogenous calcitonin gene-related peptide in severe necrotizing pancreatitis. Pancreatology. 2009;9(5):662-669.
12. Bernik TR, Friedman SG, Ochani M, et al. Pharmacological stimulation of the cholinergic antiinflammatory pathway. J Exp Med. 2002;195(6):781-788. (Pubitemid 34259722)
13. de Jonge WJ, van der Zanden EP, The FO, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol. 2005;6(8):844-851. (Pubitemid 43090471)
14. Saeed RW, Varma S, Peng-Nemeroff T, et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med. 2005;201(7):1113-1123. (Pubitemid 40524679)
15. van Westerloo DJ, Giebelen IA, Florquin S, et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis. 2005;191(12):2138-2148. (Pubitemid 40800586)
16. van Westerloo DJ, Giebelen IA, Florquin S, et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology. 2006;130(6):1822-1830.
17. Pavlov VA, Ochani M, Yang LH, et al. Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med. 2007;35(4):1139-1144. (Pubitemid 46598966)
18. Beilin B, Bessler H, Papismedov L, et al. Continuous physostigmine combined with morphine-based patient-controlled analgesia in the postoperative period. Acta Anaesthesiol Scand. 2005;49(1):78-84. (Pubitemid 40214858)
19. Schmidt J, Rattner DW, Lewandrowski K, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg. 1992;215(1):44-56.
20. Hartwig W, Carter EA, Jimenez RE, et al. Chemotactic peptide uptake in acute pancreatitis: correlation with tissue accumulation of leukocytes. J Appl Physiol. 1999;87(2):743-749. (Pubitemid 29375012)
21. McKay CJ, Imrie CW. The continuing challenge of early mortality in acute pancreatitis. Br J Surg. 2004;91(10):1243-1244. (Pubitemid 39331447)
22. Ceranowicz D, Warzecha Z, Dembinski A, et al. Role of hormonal axis, growth hormone - IGF-1, in the therapeutic effect of ghrelin in the course of cerulein-induced acute pancreatitis. J Physiol Pharmacol. 2010;61(5):599-606.
23. Chen Q, Vera-Portocarrero LP, Ossipov MH, et al. Attenuation of persistent experimental pancreatitis pain by a bradykinin b2 receptor antagonist. Pancreas. 2010;39(8):1220-1225.
24. Hackert T, Sperber R, Hartwig W, et al. P-selectin inhibition reduces severity of acute experimental pancreatitis. Pancreatology. 2009;9(4):369-374.
25. Hackert T, Tudor S, Felix K, et al. Effects of pantoprazole in experimental acute pancreatitis. Life Sci. 2010;87 (17-18):551-557.
26. Hackert T, Werner J. Antioxidant therapy in acute pancreatitis: experimental and clinical evidence. Antioxid Redox Signal. 2011;15(10):2767- 2777.
27. Hu G, Shen J, Cheng L, et al. Reg4 protects against acinar cell necrosis in experimental pancreatitis. Gut. 2011;60(6):820-828.
28. Jin HT, Lamsa T, Nordback PH, et al. Association between remote organ injury and tissue polyamine homeostasis in acute experimental pancreatitisVtreatment with a polyamine analogue bismethylspermine. Pharmacol Rep. 2011;63(4):999-1008.
29. Joo KR, Shin HP, Cha JM, et al. Effect of Korean red ginseng on superoxide dismutase inhibitor-induced pancreatitis in rats: a histopathologic and immunohistochemical study. Pancreas. 2009;38(6):661-666.
30. Minutoli L, Squadrito F, Nicotina PA, et al. Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway. Crit Care Med. 2011;39(5):1089-1096.
31. Paszt A, Eder K, Szabolcs A, et al. Effects of glucocorticoid agonist and antagonist on the pathogenesis of L-arginineYinduced acute pancreatitis in rat. Pancreas. 2008;36(4):369-376. (Pubitemid 351591579)
32. Pezzilli R. Pharmacotherapy for acute pancreatitis. Expert Opin Pharmacother. 2009;10(18):2999-3014.
33. Polito F, Bitto A, Irrera N, et al. Flavocoxid, a dual inhibitor of cyclooxygenase-2 and 5-lipoxygenase, reduces pancreatic damage in an experimental model of acute pancreatitis. Br J Pharmacol. 2010;161(5):1002-1011.
34. Schneider L, Hackert T, Longerich T, et al. Effects of gadolinium chloride and glycine on hepatic and pancreatic tissue damage in alcoholic pancreatitis. Pancreas. 2010;39(4):502-509.
35. Tang Y, Liao Y, Kawaguchi-Sakita N, et al. Sinisan, a traditional Chinese medicine, attenuates experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats. J Hepatobiliary Pancreat Sci. 2011;18(4):551-558.
36. Uysal B, Yasar M, Ersoz N, et al. Efficacy of hyperbaric oxygen therapy and medical ozone therapy in experimental acute necrotizing pancreatitis. Pancreas. 2010;39(1):9-15.
37. Wang G, Sun B, Zhu H, et al. Protective effects of emodin combined with danshensu on experimental severe acute pancreatitis. Inflamm Res. 2010;59(6):479-488.
38. Werner J, Hartwig W, Hackert T, et al. Multidrug strategies are effective in the treatment of severe experimental pancreatitis. Surgery. 2012;151(3):372-381.
39. Zhang XP, Jiang J, Cheng QH, et al. Protective effects of Ligustrazine, Kakonein and Panax Notoginsenoside on the small intestine and immune organs of rats with severe acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2011;10(6):632-637.
40. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421(6921):384- 388. (Pubitemid 36157937)
41. Rosas-Ballina M, Tracey KJ. Cholinergic control of inflammation. J Intern Med. 2009;265(6):663-679.
42. Hofer S, Eisenbach C, Lukic IK, et al. Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med. 2008;36(2):404-408. (Pubitemid 351158611)
43. Liliensiek B, Weigand MA, Bierhaus A, et al. Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J Clin Invest. 2004;113(11):1641-1650. (Pubitemid 39071688)
44. Gold JA, Parsey M, Hoshino Y, et al. CD40 contributes to lethality in acute sepsis: in vivo role for CD40 in innate immunity. Infect Immun. 2003;71(6):3521-3528. (Pubitemid 36637581)
45. Bohrer H, Qiu F, Zimmermann T, et al. Role of NFkappaB in the mortality of sepsis. J Clin Invest. 1997;100(5):972-985.
46. Schneider L, Pietschmann M, Hartwig W, et al. Inosine reduces microcirculatory disturbance and inflammatory organ damage in experimental acute pancreatitis in rats. Am J Surg. 2006;191(4):510-514. (Pubitemid 43384148)